Top Page
Audeara Ltd.
(Sydney:AUA)
Audeara Ltd. (AUA) vs. iShares MSCI Australia ETF (EWA)
Audeara Ltd. Business Overview & Revenue Model
Audeara Ltd. Financial Statement Overview
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 3.79M | 3.79M | 3.19M | 2.91M | 2.07M | 1.12M |
| Gross Profit | 1.36M | 1.36M | 943.12K | 1.14M | 946.11K | 510.33K |
| EBITDA | -2.90M | -2.90M | -2.75M | -3.80M | -3.07M | -1.08M |
| Net Income | -1.79M | -1.79M | -1.60M | -3.74M | -2.95M | -1.25M |
Balance Sheet | ||||||
| Total Assets | 4.30M | 4.30M | 4.89M | 4.73M | 5.49M | 6.57M |
| Cash, Cash Equivalents and Short-Term Investments | 1.42M | 1.42M | 1.27M | 2.62M | 2.87M | 5.74M |
| Total Debt | 1.12M | 1.12M | 112.18K | 210.74K | 275.11K | 67.60K |
| Total Liabilities | 3.01M | 3.01M | 3.28M | 1.57M | 1.41M | 665.76K |
| Stockholders Equity | 1.29M | 1.29M | 1.61M | 3.17M | 4.08M | 5.91M |
Cash Flow | ||||||
| Free Cash Flow | -1.95M | -1.95M | -1.34M | -2.98M | -3.78M | -1.11M |
| Operating Cash Flow | -1.81M | -1.81M | -1.33M | -2.97M | -3.58M | -1.08M |
| Investing Cash Flow | -149.02K | -149.02K | -8.47K | -16.00K | -229.26K | -23.71K |
| Financing Cash Flow | 2.08M | 2.08M | -10.88K | 2.74M | 939.73K | 7.10M |
Audeara Ltd. Technical Analysis
Audeara Ltd. Peers Comparison
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
48 Neutral | AU$7.01M | ― | -684.77% | ― | 8.64% | 33.88% | |
47 Neutral | AU$6.12M | ― | -123.13% | ― | 18.86% | -14.41% | |
39 Underperform | AU$13.17M | ― | ― | ― | -51.64% | -21.74% | |
38 Underperform | AU$8.21M | ― | -135.89% | ― | -21.60% | -657.00% | |
23 Underperform | AU$181.10M | ― | ― | ― | -100.00% | 44.26% |
Audeara Ltd. Corporate Events
Audeara Ltd. announced a proposed issue of securities, including 4,250,000 unlisted options and 954,763 ordinary fully paid shares, set to be issued on November 26, 2025. This move is part of the company’s strategic efforts to enhance its capital structure and potentially strengthen its market position, offering stakeholders an opportunity to engage with the company’s growth trajectory.
Audeara Ltd. has announced its Annual General Meeting (AGM) to be held on November 25, 2025, in Brisbane. The meeting will address several key resolutions, including the adoption of the Remuneration Report, the re-election of Mr. Hsin-Chieh (Bill) Peng as a Director, approval of a mandate to issue equity securities, and the issuance of shares to Mr. David Trimboli in lieu of director’s fees. Shareholders are encouraged to vote by proxy, and the outcomes of these resolutions could impact the company’s governance and financial strategies.
Audeara Ltd reported a significant increase in revenue for Q1 FY26, driven by its AUA Technology division and a substantial rise in Australian wholesale sales. The company secured a licensing agreement with Eastech to provide hearing technology for the Chinese market and expanded its international reach with a distribution agreement in Japan. These developments, along with a reduction in net cash outflows, position Audeara towards achieving cashflow breakeven and enhancing its global market presence.
Audeara Limited has secured its first purchase order for the Chinese hearing aid market through a licensing agreement with Eastech (Huizhou) Co., Ltd., marking a significant step in its global expansion. The order for 1,000 hearing aid technology license keys signifies initial commercial traction in China, a market with substantial growth potential due to its large population affected by hearing loss. The products will be sold under a third-party brand via leading Chinese e-commerce platforms, potentially reaching millions of consumers. This development underscores Audeara’s strategic entry into one of the largest healthcare markets, with future financial impacts dependent on market uptake and subsequent orders.
Audeara Limited has entered into a non-exclusive distribution agreement with Eyear System Inc., a Tokyo-based audiology and hearing solutions company, to introduce its Auracast™-enabled products in Japan. This partnership marks Audeara’s first international expansion of its new product suite, following successful implementations in Australia. The collaboration aims to accelerate the availability of Audeara’s products in Japan’s advanced hearing-health sector, with an initial order of 100 units and plans for joint exhibition at a major healthcare event. This move strengthens Audeara’s international presence and positions it as a key player in the global hearing technology market.
Audeara Limited has announced its Annual General Meeting (AGM) scheduled for November 25, 2025, in Brisbane, with a closing date for director nominations set for October 14, 2025. This meeting will provide an opportunity for stakeholders to engage with the company’s leadership and discuss future directions, potentially impacting Audeara’s strategic positioning in the hearing health industry.
Audeara Ltd. has announced the issuance of 4,200,000 unquoted options, set to expire on September 10, 2028, with an exercise price of $0.045. This move is part of an employee incentive scheme, indicating the company’s strategy to retain talent and motivate its workforce. The issuance of these securities could impact the company’s financial structure and is a signal of its commitment to growth and employee engagement.
Audeara Limited has released its corporate governance statement for the financial year ending June 30, 2025, which is available on their website. The statement has been approved by the board and outlines the company’s adherence to the ASX Corporate Governance Council’s recommendations, ensuring transparency and accountability in its management and oversight practices.
Audeara Ltd. has reaffirmed its commitment to high standards of corporate governance by adopting the ASX Corporate Governance Council’s Principles and Recommendations. The company has implemented a Board Charter and various policies to delineate the roles and responsibilities of its board and management, ensuring transparency and accountability in its operations.
Audeara Ltd. reported an 18.87% increase in revenues for the financial year ending June 30, 2025, reaching $3.786 million. Despite the revenue growth, the company experienced a net loss of $1.787 million, an 11.48% increase from the previous year, indicating ongoing financial challenges. No dividends were declared for the current or prior year, and the net tangible asset backing per share decreased to 0.69 cents from 1.1 cents, reflecting a decline in shareholder value.
Audeara Limited reported a 46% increase in unaudited revenue for Q1 FY26, reaching $1.05 million, driven by strong sales in Australian wholesale channels and a significant order from Avedis Zildjian. The company is poised for further growth with its recent agreement to enter the Chinese medical device market and its recognition as a finalist in multiple export awards, highlighting its expanding international footprint.
Audeara Limited has entered a Licensing Agreement with Eastech (Huizhou) Co., Ltd. to introduce its hearing technology into the Chinese market. This strategic partnership will leverage Eastech’s regulatory capabilities and e-commerce distribution channels to reach millions of consumers in China, where hearing loss is a significant issue. The collaboration marks a crucial step in Audeara’s global expansion strategy, with the product launch expected in the latter half of 2025. The agreement, which includes royalties per unit sold, is set for an initial five-year term and is anticipated to enhance Audeara’s market positioning in the hearing health industry.
Audeara Limited has partnered with the Ear Science Institute Australia to develop and evaluate bone conduction hearing solutions aimed at high-need communities in Australia. The collaboration, supported by a $100,000 contribution from ESIA, will focus on improving access to hearing support for children in classroom settings, with the potential to enhance educational and social participation while opening commercial opportunities in underserved markets.